William J. Federici
Independent DirectorMr. William J. Federici, also known as Bill, has been Independent Director of Stevanato Group S.p.A. since May 2021. He was a member of the board of directors of Zynerba Pharmaceuticals, Inc., since August 06, 2015 until October of 2023. He was Advisor of West Pharmaceutical Services Inc. since June 21, 2018 until 2019. Mr. Federici served as Chief Financial Officer and Senior Vice President of West Pharmaceutical Services Inc. since August 2003 until June 21, 2018 and had been its Treasurer since January 2017 until June 21, 2018. Mr. Federici served as Vice President West Pharmaceutical Services Inc. since August 2003. Mr. Federici served as a National Industry Director for Pharmaceuticals at KPMG LLP from June 2002 to August 2003. Prior thereto, he was an Audit Partner of Arthur Andersen LLP. He has many years of experience in public accounting for the pharmaceutical industry. He served as practice leader for the pharmaceuticals industry in the Americas and engagement Partner for several pharmaceutical companies at KPMG LLP. Mr. Federici served as a Director of NuPathe Inc from January 5, 2011 to February 2014. He serves as an Advisory Board Member of the Rutgers University School of Business and a Member of the Board of Trustees at Cancer Care of New Jersey. Mr. Federici holds a BA degree in Economics from Rutgers University, Livingston College and an MBA degree in Professional Accounting from the Rutgers University and is a member of the American Institute of Certified Public Accountant.
Positions
- Company NameStevanato Group S.p.A.Stock CodeSTVNPositionIndependent DirectorColleagues
- FSFranco StevanatoCEO & Executive Chairman
- MDMarco Dal LagoChief Financial Officer
- LMLisa MilesChief Communications & Investor Relations Officer
- CCCarla CostaChief Human Resources Officer
- MSMauro StocchiChief Business Strategy Officer
- SSSergio StevanatoEmeritus Chairman
- MBMadhavan BalachandranIndependent Director
- KAKaren A. FlynnIndependent Director
